Gabapentin
Product Images NDC 70010-108

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70010-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba-fig-1-jpg.jpg (Gaba Fig 1 Jpg)

A line graph comparing mean pain scores over an 8-week period for Gabapentin 3600 mg/day and placebo. The x-axis represents weeks, including baseline through week 8, with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score trend, while placebo scores remain relatively stable.*

FDA Label Image

Gaba-fig-2-jpg.jpg (Gaba Fig 2 Jpg)

A line graph showing mean pain score over 7 weeks comparing placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks including baseline, and the y-axis shows mean pain score from 0 to 10. The graph illustrates a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Gaba-fig-3-jpg.jpg (Gaba Fig 3 Jpg)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing results from two studies. Study 1 compares placebo (12%) with Gabapentin 3600 mg (29%). Study 2 compares placebo (14%) with Gabapentin 1800 mg (32%) and Gabapentin 2400 mg (34%). Statistical significance marked for Gabapentin groups versus placebo.*

FDA Label Image

Gaba-fig-4-jpg.jpg (Gaba Fig 4 Jpg)

A scatter plot chart showing the percentage difference on the y-axis versus daily dose in mg on the x-axis. The chart compares data points from three studies labeled as STUDY a, STUDY b, and STUDY c, represented by black, gray, and white squares respectively, across daily doses of approximately 600, 900, 1200, and 1800 mg.*

FDA Label Image

Gaba-structure.jpg (Gaba Structure)

Chemical structure diagram of gabapentin, showing its cyclohexane ring with attached amino and carboxyl functional groups as part of its molecular structure.*

FDA Label Image

Gabapentin 100mg 100 Jpg

Gabapentin Capsules, USP 100 mg in a bottle label format. The label indicates the product contains 100 capsules, each with 100 mg of gabapentin. It includes storage instructions, manufacturer details of Granules India Limited and Granules Pharmaceuticals Inc., and a barcode. The label specifies prescription use and directs pharmacists to dispense the enclosed medication guide.*

FDA Label Image

Gabapentin 100mg 1000 Jpg

Gabapentin Capsules, USP 100 mg label from Granules Pharmaceuticals Inc. The label indicates a package of 1000 capsules, each containing 100 mg gabapentin. It includes storage instructions for controlled room temperature and dispensing guidelines. Manufactured by Granules India Limited, India, and labeled for Granules Pharmaceuticals Inc., Chantilly, VA.*

FDA Label Image

Gabapentin 100mg 500 Jpg

Gabapentin Capsules USP 100 mg packaging label from Granules Pharmaceuticals Inc. The label states each capsule contains 100 mg gabapentin, includes storage instructions, and notes the medication guide should be dispensed to each patient. It shows NDC 70010-108-05 and that it is manufactured by Granules India Limited in India for Granules Pharmaceuticals Inc., Chantilly, VA.*

FDA Label Image

Gabapentin 300mg 100 Jpg

Gabapentin Capsules, USP 300 mg label showing container of 100 capsules. The label includes storage instructions, dosage reminder to see package insert, and manufacturer information for Granules Pharmaceuticals Inc. and Granules India Limited. A barcode and NDC number 70010-109-01 are also visible.*

FDA Label Image

Gabapentin 300mg 1000 Jpg

Gabapentin Capsules, USP 300 mg label showing the product name, strength, and dosage form. The label includes storage instructions, manufacturer details (Granules India Limited, Hyderabad, India), and manufacturer for Granules Pharmaceuticals Inc., Chantilly, VA, plus a note for pharmacists to dispense the medication guide separately. The NDC 70010-109-10 is visible along with barcodes and dosage information.*

FDA Label Image

Gabapentin 300mg 500 Jpg

Gabapentin Capsules, USP 300 mg label from Granules Pharmaceuticals Inc. The carton provides storage instructions, dosage form, capsule count of 500, and manufacturer details indicating production by Granules India Limited, Hyderabad, India. The label also includes handling guidance for pharmacists and a barcode with NDC 70010-109-05.*

FDA Label Image

Gabapentin 400mg 100 Jpg

Label for Gabapentin Capsules, USP 400 mg, containing 100 capsules. The label states the storage conditions (20°C to 25°C) with permitted excursions, instructions to dispense a Medication Guide to each patient, and manufacturing details including Granules India Limited in Hyderabad, India and Granules Pharmaceuticals Inc. in Chantilly, VA. The label includes an NDC barcode and an Rx only designation.*

FDA Label Image

Gabapentin 400mg 1000 Jpg

Gabapentin Capsules, USP 400 mg packaging label from Granules Pharmaceuticals Inc. The label indicates each capsule contains 400 mg gabapentin and that the bottle contains 1000 capsules. Storage instructions specify keeping at 20°C to 25°C with allowed excursions from 15°C to 30°C. The product is manufactured by Granules India Limited in Hyderabad, India, and labeled by Granules Pharmaceuticals Inc., Chantilly, VA. The label includes a barcode and a note for pharmacists to dispense the medication guide separately.*

FDA Label Image

Gabapentin 400mg 500 Jpg

GABAPENTIN Capsules, USP 400 mg packaging label for 500 capsules. The label indicates the product contains 400 mg gabapentin per capsule, with storage instructions and manufacturer details listing Granules India Limited, Hyderabad, India, and Granules Pharmaceuticals Inc. as the labeler. The NDC number 70010-118-05 and barcode are visible.*

FDA Label Image

Gabapentin-formula-jpg.jpg (Gabapentin Formula Jpg)

A formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a factor for female patients. This equation is likely part of a drug information or dosing guideline panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.